Does arginase blockade protect against hepatic damage in warm ischemia-reperfusion?
Arginase blockade represents a potentially novel strategy to combat liver injury under conditions of arginine deficiency. This protection may be mediated through the arginine-NO pathway.
Polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans.